SPOTLIGHT: Amgen touts Aranesp data


Fighting to retain its multibillion-dollar market in anemia drugs, Amgen has released new data that shows Aranesp is safe and effective for treating anemia in cancer patients. Report

Suggested Articles

After delivering a "positive surprise" in December, Biogen is painting a fuller picture of its lupus drug.

A new CRISPR technique neutralizes SARS-CoV-2 by scrambling the virus' genetic code. It could prove useful for fighting other viruses, like influenza.

The deal, which follows a bidding war with AcelRx, gives Melinta another approved antibiotic and potentially complementary R&D expertise.